Denali Therapeutics Inc. (DNLI) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Denali Therapeutics Inc., Ultragenyx Pharmaceutical Inc..Total Return (%)
Denali Therapeutics Inc. (DNLI)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Denali Therapeutics Inc.
DNLI
Ultragenyx Pharmaceutical Inc.
RARE
| Metric | Denali Therapeutics Inc. (DNLI) | Ultragenyx Pharmaceutical Inc. (RARE) |
|---|---|---|
| Current Price | $16.92 | $31.86 |
| Change | -0.56 (-3.20%) | -0.97 (-2.95%) |
| Market Cap | $2.48B | $3.07B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -6.15 | -6.23 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $26.18 | $50.00 |
| 52-Week Low | $10.57 | $25.81 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.92 | $-5.93 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| DNLI | -0.24% | -26.56% | -30.14% | -72.81% | -21.12% | -21.12% |
| RARE | -6.81% | -22.82% | -30.77% | -72.22% | -67.74% | -66.08% |